×

News & Press

Subscribe to receive updates and news


Join the KDIGO Mailing List

gokdigo KDIGO @gokdigo ·
2 Jun

Are you attending #ERA26 in Glasgow? Don’t miss the GSK–KDIGO symposium on preventing infectious diseases in adults with kidney disease and closing the implementation gap in vaccination uptake.

Thursday, 4 Jun, 13:00 - 14:00 BST. Learn more: https://pag.virtual-meeting.org/.../en-GB/pag/session/86280

The session

Reply on Twitter 2061760637819146317 Retweet on Twitter 2061760637819146317 Like on Twitter 2061760637819146317 4 Twitter 2061760637819146317
gokdigo KDIGO @gokdigo ·
1 Jun

Are you attending #ERA26 in Glasgow? Don't miss the KDIGO scientific symposium "What's New with KDIGO," on Saturday, 6 June, 08:30–10:30 BST.

Learn more: https://kdigo.co/ERA26-KDIGO-Symposium

From advances in Diabetes and CKD to the evolving cardiovascular–kidney–metabolic (CKM)

Reply on Twitter 2061405949076636136 Retweet on Twitter 2061405949076636136 2 Like on Twitter 2061405949076636136 5 Twitter 2061405949076636136
Retweet on Twitter KDIGO Retweeted
arkanalabs Arkana Laboratories @arkanalabs ·
29 May

A sample from the pathology teaching slide set on Lupus Nephritis, jointly prepared by Arkana Laboratories and @goKDIGO. http://KDIGO.org/guidelines/gd/

#KDIGO #pathology #renal #kidneypath

Reply on Twitter 2060346064817852426 Retweet on Twitter 2060346064817852426 3 Like on Twitter 2060346064817852426 11 Twitter 2060346064817852426
Load More
KDIGO to Assess the Impact of the SPRINT Trial on its 2012 Blood Pressure Guideline

BRUSSELS, BELGIUM – Kidney Disease: Improving Global Outcomes (KDIGO) is committed to keeping its guidelines up-to-date. Following the publication of the results of the Systolic Blood Pressure Intervention Trial (SPRINT) in the New England Journal of Medicine on November 9th, KDIGO is planning to reexamine the recommendations contained in the KDIGO Clinical Practice Guideline for

News December 10, 2015

Load More